Patient Rating:

4.6 out of 5

42 Patient Ratings
24 Patient Comments

Norman L. Foster, M.D.

Chief, Division of Cognitive Neurology

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 585-7575 Imaging and Neurosciences Center
Cognitive Disorders Clinic
729 Arapeen Way
Salt Lake City, UT 84108
Map

Bio

Dr. Norman Foster is a board certified geriatric neurologist who has specialized in brain imaging and dementing and neurodegenerative diseases for over 30 years. In 2005, Dr. Foster’s passion for improving Alzheimer's care brought him to the University of Utah, where he helped establish the first academic clinic in the Intermountain West devoted to caring for Alzheimer's disease and related disorders – the Center for Alzheimer's Care, Imaging and Research (CACIR).

Dr. Foster sees patients in CACIR’s sub-specialty Cognitive Disorders Clinic. His clinical interests include a broad spectrum of neurodegenerative diseases, including Alzheimer’s disease, frontotemporal dementia, and dementia that is atypical, rapidly progressive, early-onset, focal, or familial.

Dr. Foster also conducts extensive research in cognitive neurology and brain imaging.

Board Certification and Academic Information

Academic Departments Neurology - Professor
Academic Divisions Cognitive Neurology
Board Certification American Board of Psychiatry & Neurology (Neurology)
United Council for Neurologic Subspecialties (Geriatric Neurology)

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
4.7
My confidence in care provider
4.6
Time care provider spent with me
4.8
Care provider spoke using clear language
4.6
Care provider's effort to include me in decisions
4.4
Care provider's concern for questions & worries
4.6
Care provider's explanation of condition/problem
4.7
Wait time at clinic
4.3
Care provider's friendliness and courtesy
4.8

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

June 16, 2014

did not seem very organized and not sure he had all the test results from all the tests. This is a guess, but it seemed that way to me.

May 19, 2014

after a few brief questions, I was told I probably had Alzheimer's . I'm sure you see many patients but I left feeling like I was doomed after such a brief exam.

April 06, 2014

Once again we are very lucky to have Norman Foster as a doctor

March 28, 2014

seem their biggest concern was how good our health insurance was

February 03, 2014

some uncertainty as who would talk to primary care provider about Rx recommendations.

January 12, 2014

we like Dr Foster- he presents a very personal, encouraging & caring relationship

November 14, 2013

Good

August 19, 2013

We left with no idea of how to proceed; why we needed another mri; just treatment ideas and information etc. We may consult another physician.

July 31, 2013

Dr Foster appears to be very experienced in dealing with the type of medical problems that my uncle is presenting. Sometimes we wonder what difference it could have made if we had had the chance to have seen him a year or two prior (with hindsight!).

May 29, 2013

The clinic is excellent in sharing a scary diagnosis in a candid yet compassionate manner. I am grateful for both.

May 07, 2013

Dr Foster is awesome!

April 22, 2013

I would recommend the staff to all. They are great

April 04, 2013

Patient did not feel like she was included in the discussion. Dr. Foster spoke with family instead of directing the conversation to her. She indicated that she felt like a illness instead of a person when he was directing teaching to resident (?).

March 04, 2013

I believe should have provided more information about what the initial testing revealed. A little bit condescending.

November 07, 2012

We felt comfortable with the counsel and direction Dr Foster gave to us. We value his expertise and know we are on the right track if we follow his advise.

October 22, 2012

Dr Foster was awesome. Obviously knows what he is doing and instills confidence. My wife is looking forward to her next visit with him when he expects to confirm with her what is going on. She is comfortable with whatever the outcome is.

October 18, 2012

dr. foster was very helpful in sorting out my memory loss problem.

October 08, 2012

We feel we had the very best of care

October 04, 2012

We had not received the notes from the first visit so we were not fully prepared for the discussion. Dr. Foster had to take more time explaining all of those things at the onset of the discussion. This took up more of his time. He did not seem to rush over anything even though this took longer.

September 20, 2012

The doctor had a tendency to speak in doctor jargon which was a bit hard to understand. However he was very polite.

August 09, 2012

Dr. Foster was very personable. He made us feel comfortable about the next steps and required testing for her condition. She was very at ease with him.

May 21, 2012

Dr Foster has a way of providing pertinent information in a positive way that we can understand. We feel he is sincerely concerned, and highly qualified in his field. We appreciate the care we've received. The care goes beyond diagnosis, to include ways of coping, in a proactive format before needs arise.

March 19, 2012

We both feel comfortable with the doctor and his team and have extremely high confidence in his capacity and desire to help.

January 23, 2012

good

Academic Profile

Research Interests

  • Frontotemporal Dementia
  • Brain Imaging
  • PET Markers in Dementia
  • Alzheimer's Disease
  • Neurodegenerative Disorders

Board Certification and Academic Information

Academic Departments Neurology - Professor
Academic Divisions Cognitive Neurology
Board Certification American Board of Psychiatry & Neurology (Neurology)
United Council for Neurologic Subspecialties (Geriatric Neurology)

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 587-7236 Center for Alzheimer's Care, Imaging & Research
650 Komas
Salt Lake City, UT 84108

Academic Bio

Norman L. Foster, M.D., is Professor in the Department of Neurology, Chief of the Division of Cognitive Neurology, Director of the Center for Alzheimer's Care, Imaging and Research (CACIR), and Senior Investigator for the Brain Institute at the University of Utah. He is a member of the Utah Commission on Aging, and a member of the University of Utah Center on Aging steering committee.

Dr. Foster has been nominated by his peers as one of the Best Doctors in America® from 1996 to 2013. He was recognized as a "Health Care Hero" by Utah Business Magazine in 2007 for his clinical innovations at the University of Utah, and he received the ALEXA Award (for a Lifetime of Extraordinary Achievement in Alzheimer’s care and research) from the Utah Chapter of the Alzheimer’s Association in 2010. In 2011, Dr. Foster was appointed as a member of the Utah State Governor’s Alzheimer’s State Plan Task Force.

Dr. Foster received his M.D. from the Washington University School of Medicine in St. Louis. After completing his residency in Neurology at the University of Utah in Salt Lake City, Dr. Foster relocated to Bethesda, Maryland for a three-year fellowship in Experimental Therapeutics with the National Institute of Neurological and Communicative Disorders and Stroke (NINDS) at the NIH.

Dr. Foster was a faculty member of the University of Michigan Department of Neurology for over 20 years. During his tenure, he developed the first clinical program for dementing disorders in the state of Michigan, which eventually formed the nucleus of the Clinical Core of the NIH-funded Michigan Alzheimer’s Disease Research Center, which Dr. Foster directed for the first 16 years of its funding from 1989 to 2005. He also served as Associate Director of the Michigan ADRC from 1994-2004.

Dr. Foster is a Fellow of the American Academy of Neurology, and a chartered member of the Alpha Omega Alpha Honorary Medical Society and the American Neurological Association. He has been a chartered member of the NIH Clinical Neuroscience and Neurodegeneration (CNN) Study Section since 2007, and served as Section Chair from 2010-11.

Dr. Foster’s recent research has focused on pragmatic studies to improve evaluation, diagnosis and treatment of cognitive disorders. This includes the development and application of brain imaging, especially validating imaging in clinical care. Dr. Foster recently led two multi-center NIH-funded trials of FDG-PET imaging to distinguish Alzheimer’s disease from frontotemporal dementia, which led to a decision by Medicare to fund FDG-PET for this indication. He is an investigator in the Neuroimaging Core of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and leads the University of Utah component of that study. He also has been involved in numerous studies examining the process of evaluating dementia. He is a member of the diagnostic consensus panel for the Aging and Demographics and Memory Study (ADAMS) and was elected by the NIH-funded Alzheimer’s Centers to serve on the committee that developed the Uniform Data Set (UDS) now used at all of the Centers as a basis for evaluation and monitoring longitudinal change in cognition. Dr. Foster also has been involved with many clinical trials, including investigator-initiated, NIH-funded, and drug company sponsored drug trials.

Education

Education History

Type School Degree
Fellowship National Institute of Neurological & Communicative Disorders
Medical Therapeutics
Fellow
Residency University of Utah School of Medicine
Neurology
Resident
Internship Jewish Hospital of St. Louis, Washington Univ Medical Center
Medicine
Intern
Professional Medical Washington University
Medicine
M.D.
Undergraduate MacMurray College
Biology and Chemistry
B.A.

Publications

Selected Provider Publications

Journal Article

  1. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Carrillo MC, Hartley DM, Hedrick S, Pappas V, Thies WH (2013). Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. Alzheimers Dement, 9(1), e-1-16.
  2. Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education.Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Hedrick S, Pappas V, Carrillo MC, Hartley DM (2013). Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. J Nucl Med, 54(7), 1011-3.
  3. Strong evidence for a genetic contribution to late-onset Alzheimer's disease mortality: a population-based study.Kauwe JS, Ridge PG, Foster NL, Cannon-Albright LA (2013). Strong evidence for a genetic contribution to late-onset Alzheimer's disease mortality: a population-based study. PLoS One, 8(10), e77087.
  4. Womack KB, Diaz-Arrastia R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Clark CM, Decarli CS, Jagust WJ, Leverenz JB, Peskind ER, Turner RS, Zamrini EY, Heidebrink JL, Burke JR, Dekosky ST, Farlow MR, Gabel MJ, Higdon R, Kawas CH, Koeppe RA, Lipton AM, Foster NL (2011). Temporoparietal Hypometabolism in Frontotemporal Lobar Degeneration and Associated Imaging Diagnostic Errors. Arch Neurol, 68(3), 329-37.
  5. Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA, Alzheimers Disease Neuroimaging Initiative (2010). The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimer's & Dementia, 6(3), 221-9.
  6. Gabel MJ, Foster NL, Heidebrink JL, Higdon R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Burke JR, Clark CM, Dekosky ST, Farlow MR, Jagust WJ, Kawas CH, Koeppe RA, Leverenz JB, Lipton AM, Peskind ER, Turner RS, Womack KB, Zamrini EY (2010). Validation of consensus panel diagnosis in dementia. Arch Neurol, 67(12), 1506-12.
  7. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, DeCarli CS, Turner RS, Koeppe RA, Higdon R, Minoshima S (2007). FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain, 130(Pt 10), 2616-35.

Book Chapter

  1. Foster NL (2012). Neuroimaging. In Weiner MF, Lipton AM (Ed.), Clinical Manual of Alzheimer Disease and Other Dementias (pp. 89-126). Washington DC: American Psychiatric Publishing, Inc.
  2. Foster NL (2011). Molecular Imaging in Neuropsychiatry. In Coffey CE, Cummings JL (Ed.), The American Psychiatric Publishing Textbook of Geriatric Neuropsychiatry (3rd Ed, pp. 177-209). Washington: American Psychiatric Publishing, Inc.
  3. Foster NL (2009). Neuroimaging. In Weiner MF, Lipton AM (Ed.), The American Psychiatric Publishing Textbook of Alzheimer Disease and Other Dementias (pp. 105-136). Washington: American Psychiatric Publishing, Inc.

Editorial

  1. A peek behind the curtain: amyloid imaging, referrals, and specialist memory evaluations.Foster NL, Jagust WJ, Fox NC (2013). A peek behind the curtain: amyloid imaging, referrals, and specialist memory evaluations. Alzheimer Dis Assoc Disord, 27(1), 1-3.

Clinical Trials

Clinical Trials

Video & News

The Scope Health Sciences Radio

Video